13F filing recap · Q3 2023
What did Patient Capital Management buy in Q3 2023?
Reported stock-position changes between this filing and the previous one.
Stock value
$1.70B
Positions
41
Estimated turnover
23.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.